07 Jan 2001

MCP Hexal® (MCP Hexal® 10 Tabletten) - Deutschland

Updated: 07 Jan 2001

MCP Hexal® 10; -Tropfen; -injekt

Motilitätsstör. des oberen Magen-Darmtraktes. Übelkeit u. Erbrechen, Brechreiz. Zusätzlich bei Inj.-lsg.: z. Erleichterung der Duodenal- u. Jejunalsondierung. Beschleunigung der Magenentleerung und Dünndarmpassage bei d. röntgenologischen Untersuchung.

MCP Hexal® Description, Presentation and Dosage

MCP Hexal® Description

MCP Hexal® Drug Class Description

Einzelstoffe

MCP Hexal® Drug Description

1 Tbl. enth.: Metoclopramid-HCl 1H2O 10,53 mg (entspr. 10 mg Metoclopramid-HCl).

MCP Hexal® Generic Name

MCP Hexal® 10 Tabletten

MCP Hexal® Presentation

MCP Hexal® Presentation

MCP Hexal® 10; -Tropfen; -injekt

MCP Hexal® Manufacturer

Hexal

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

MCP Hexal® Dosage

MCP Hexal® Adult Dosage

Calciumhydrogenphosphat, Lactose, Magnesiumstearat, Poly(O-carboxymethyl)stärke-Natrium, Maisstärke, Siliciumdioxid. ger. Wasser.

MCP Hexal® Child Dosage


MCP Hexal® Tropfen
Zus.: 1 ml (ca. 15 Tr.) enth.: Metoclopramid-HCl 1H2O 4,21 mg (entspr. 3,56 mg Metoclopramid bzw. 4 mg Metoclopramid-HCl).
Weit. Bestandteile: Methyl-4-hydroxybenzoat 1,3 mg, Propyl-4-hydroxybenzoat 0,2 mg, Natriumcyclamat, Natriumdihydrogenphosphat, Natriummetabisulfit, Saccharin-Natrium,

MCP Hexal® injekt Injektionslösung
Zus.: 1 Amp. (2 ml) enth.: Metoclopramid-HCl 1H2O 10,53 mg (entspr. 10 mg Metoclopramid-HCl).
Weit. Bestandteile: Natriumchlorid, Wasser f. Inj.-zwecke.

MCP Hexal® Precautions, Reactions and Contraindications

MCP Hexal® Special Precautions

MCP Hexal® Special Precautions

D 70 a-f, Z 3. Säugl. u. Kleinkdr. bis 2 J.

MCP Hexal® Adverse Reactions

MCP Hexal® Adverse Reactions

D 70

Related Drugs - Gastroenterology

Back to top